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Abstract
Background: Cholesterol concentrations in blood are related to cardiovascular diseases. Recent genome-wide 
association studies (GWAS) of cholesterol levels identified a number of single-locus effects on total cholesterol (TC) and 
high-density lipoprotein cholesterol (HDL-C) levels. Here, we report single-locus and epistasis SNP effects on TC and 
HDL-C using the Framingham Heart Study (FHS) data.
Results: Single-locus effects and pairwise epistasis effects of 432,096 SNP markers were tested for their significance on 
log-transformed TC and HDL-C levels. Twenty nine additive SNP effects reached single-locus genome-wide 
significance (p < 7.2 × 10-8) and no dominance effect reached genome-wide significance. Two new gene regions were 
detected, the RAB3GAP1-R3HDM1-LCT-MCM6 region of chr02 for TC identified by six new SNPs, and the OSBPL8-
ZDHHC17 region (chr12) for HDL-C identified by one new SNP. The remaining 22 single-locus SNP effects confirmed 
previously reported genes or gene regions. For TC, three SNPs identified two gene regions that were tightly linked with 
previously reported genes associated with TC, including rs599839 that was 10 bases downstream PSRC1 and 3.498 kb 
downstream CELSR2, rs4970834 in CELSR2, and rs4245791 in ABCG8 that slightly overlapped with ABCG5. For HDL-C, LPL 
was confirmed by 12 SNPs 8-45 kb downstream, CETP by two SNPs 0.5-11 kb upstream, and the LIPG-ACAA2 region by 
five SNPs inside this region. Two epistasis effects on TC and thirteen epistasis effects on HDL-C reached the significance 
of "suggestive linkage". The most significant epistasis effect (p = 5.72 × 10-13) was close to reaching "significant linkage" 
and was a dominance × dominance effect of HDL-C between LMBRD1 (chr06) and the LRIG3 region (chr12), and this 
pair of gene regions had six other D × D effects with "suggestive linkage".
Conclusions: Genome-wide association analysis of the FHS data detected two new gene regions with genome-wide 
significance, detected epistatic SNP effects on TC and HDL-C with the significance of suggestive linkage in seven pairs 
of gene regions, and confirmed some previously reported gene regions associated with TC and HDL-C.
Background
Total cholesterol (TC) is related to coronary diseases and
high-density lipoprotein (HDL-C) cholesterol is anti-
atherogenic. Genome-wide association studies (GWAS)
and human genetic studies have identified a number of
genes and gene regions affecting cholesterol phenotypes
including TC and HDL-C [1-11]. A meta-analysis of
HDL-C levels that include the FHS data has previously
been published [2]. An early report on FHS [12] analyzed
TC and HDL-C but used 100 k SNPs and a sample size
that was much smaller than the current FHS sample size.
Epistasis analysis of TC and HDL-C was unavailable.
Here, we apply a quantitative genetics approach to detect
additive or dominance single-locus effects and epistasis
effects on log-transformed TC and HDL-C using 432,096
SNP markers and over 6000 individuals in FHS. The
epistasis effects we tested included additive × additive (A
× A), additive × dominance (A × D) or dominance × addi-
tive (D × A), and dominance × dominance (D × D) effects,
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with genetic interpretations of allele × allele, allele × gen-
otype or genotype × allele, and genotype × genotype
interactions. The single-locus analysis was intended to
detect new targets or confirm existing targets using a
method of analysis different from those used in previous
reports based on an extended Kempthorne model that
allows Hardy-Weinberger disequilibrium and linkage dis-
equilibrium [13] for GWAS analysis of the FHS data while
the epistasis analysis of TC and HDL-C was the first such
attempt using the FHS data and the 500 k SNP panel.
Results
The single-locus tests detected nine SNPs with additive
(or allelic) effects on TC and twenty SNPs with additive
effects on HDL-C that reached genome-wide significance
(Tables 1-2). No dominance effect reached genome-wide
significance. Among the twenty nine SNP effects, twenty
were new effects that were not reported in previous stud-
ies and nine were previously reported to be associated
with various cholesterol phenotypes [1-12]. Seven SNPs
identified two new gene regions while the remaining
twenty two SNPs confirmed previously reported gene
regions. Two epistasis effects on TC and thirteen epista-
sis effects on HDL-C representing seven pairs of gene
regions reached the significance of "suggestive linkage".
Single-locus effects
For TC, nine SNPs with additive (or allelic) effects
reached genome-wide significance with p < 7.2 × 10-8
(Table 1). Six SNPs inside or near four genes identified a
new chr02 region containing RAB3GAP1, R3HDM1, LCT
and MCM6 to be associated with TC (Figure 1A). Of the
six SNPs in the RAB3GAP1-R3HDM1-LCT-MCM6
region, five SNPs were inside genes and one SNP was 4.2
kb upstream MCM6. The most significant SNP in this
region was rs2322660 in intron 12 of LCT (Table 1). The
RAB3GAP1-R3HDM1-LCT-MCM6 region contained two
other genes (ZRANB3 and UBXD2) that did not have sig-
nificant SNPs. Eleven other SNPs spanning a 1.23 Mb
region (Figure 1A) that includes RAB3GAP1-R3HDM1-
LCT-MCM6 had p-values between 1.27 × 10-5 and 7.13 ×
10-7, including one SNP upstream ACMSD, one SNP in
ACMSD, two SNPs in YSK4, one SNP in R3HDM1, one
SNP in UBXD2 (also named UBXN4 according to NCBI
Table 1: Single-locus SNP effects for TC with genome control (GC) adjusted P < 7.2 × 10-8.
Effect Type & P value
SNP Chr Position Gene Region Reported SNP effect MAF Genotype Additive Effect Size
rs4970834 1 109814880 CELSR2a 
(intron 28)
Non-HDL-C [5-7] 0.18 1.10E-08 1.75E-09 0.146 ± 0.023
TC [8]
rs599839 1 109822166 10 bases 
downstream
LDL-C [6,7,9,10] 0.22 8.72E-14 2.46E-14 0.174 ± 0.021
PSRC1a Non-HDL-C [5]
rs4245791 2 44074431 ABCG8 (intron 3) 0.32 1.82E-07 3.33E-08 -0.127 ± 
0.021
rs6730157 2 135907088 RAB3GAP1 
(intron 17)
LDL-C: P = 0.018 [2]b 0.45 8.51E-08 2.16E-08 0.113 ± 0.019
rs12465802 2 136381348 R3HDM1 
(intron 7)
LDL-C: P = 0.022 [2]b 0.44 2.63E-08 7.98E-09 0.117 ± 0.019
rs4954280 2 136420690 R3HDM1 
(intron18)
LDL-C: P = 0.007 [2]b 0.33 1.49E-07 5.87E-08 0.114 ± 0.02
rs2322660 2 136557319 LCT (intron 12) LDL-C: P = 0.055 [2]b 0.35 2.42E-08 7.08E-09 -0.120 ± 
0.019
TC: P = 0.003-0.005 [17]
LDL-C: P = 0.002-0.0005 [17]
rs309180 2 136614255 MCM6 (intron 11) LDL-C: P = 0.057 [2]b 0.36 2.43E-08 8.39E-09 -0.119 ± 
0.019
rs632632 2 136638216 4.2 kb upstream 
MCM6
LDL-C: P = 0.216 [2]b 0.36 2.50E-08 1.03E-08 -0.118 ± 
0.019
a This gene was reported to be associated with TC [1].
b Available at http://www.sph.umich.edu/csg/abecasis/public/lipids2008/Ma et al. BMC Medical Genetics 2010, 11:55
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[14]), two SNPs in LCT, and three SNPs downstream
DARS (data not shown). These less significant results in
the same neighborhood should add to the significance of
the  RAB3GAP1-R3HDM1-LCT-MCM6  region to TC.
Three SNPs identified two genes that were tightly linked
with previously reported genes associated with TC [1].
These three SNPs were rs599839 that was 10 bases down-
stream PSRC1 (chr01) and 3.498 kb downstream CELSR2,
rs4970834 in intron 28 of CELSR2, and rs4245791 in
intron 3 of ABCG8 (chr02) that slightly overlapped with
ABCG5, where CELSR2  and  ABCG5  regions were
r e p o r t e d  t o  b e  a s s o c i a t e d  w i t h  T C  i n  a  r e c e n t  G W AS
report [1]. PSRC1  and  ABCG8  also were reported to
affect low-density lipoprotein cholesterol (LDL-C) [2-
4,6,7,9,10]. The SNP (rs599839) that was 10 bases down-
stream PSRC1 had the most significant single-locus effect
on TC (p = 3.7 × 10-16), while the SNP inside CELSR2
(rs4970834) had the second most significant single-locus
effect on TC (p = 1.29 × 10-10).
For HDL-C, twenty SNPs with additive effects reached
genome-wide significance (Table 2). SNP rs17259942
identified a new gene region associated with HDL-C, the
OSBPL8-ZDHHC17  region (q21.2, Figure 1B), with
rs17259942 being 117 kb downstream OSBPL8 and 85 kb
upstream ZDHHC17 [15]. According to NCBI [14], the
OSBPL8-ZDHHC17  region contained three pseudo-
genes (RPL7AP59,  RPL21P98  and  RPL7P43) and
rs17259942 was 18 kb downstream RPL21P98 and 43 kb
Table 2: Single-locus SNP effects for HDL-C with genome control (GC) adjusted P < 7.2 × 10-8.
Effect Type & P value
SNP Chr Position Gene Region Reported SNP 
effect
MAF Genotype Additive Effect Size
rs17482753 8 19832646 8 kb downstream LPLa Triglyceride [7] 0.10 1.27E-08 3.50E-09 -0.191 ± 
0.031
rs10503669 8 19847690 23 kb downstream LPLa HDL-C [4,11] 0.09 3.75E-08 1.14E-08 -0.189 ± 
0.031
rs17410962 8 19848080 23 kb downstream LPLa 0.12 2.75E-08 4.27E-09 0.173 ± 0.028
rs17489268 8 19852045 27 kb downstream LPLa 0.27 2.28E-10 5.97E-11 0.141 ± 0.02
rs17411031 8 19852310 28 kb downstream LPLa HDL-C [7] 0.27 3.06E-10 7.21E-11 -0.14 ± 0.02
rs17489282 8 19852518 28 kb downstream LPLa 0.25 2.33E-09 6.54E-10 0.14 ± 0.021
rs4922117 8 19852586 28 kb downstream LPLa 0.25 2.28E-09 7.73E-10 -0.124 ± 
0.019
rs17411126 8 19855272 31 kb downstream LPLa 0.27 6.14E-10 1.23E-10 0.138 ± 0.02
rs765547 8 19866274 42 kb downstream LPLa 0.27 1.60E-10 3.07E-11 -0.142 ± 0.02
rs11986942 8 19867445 43 kb downstream LPLa 0.33 2.22E-07 5.53E-08 0.112 ± 0.02
rs1837842 8 19868290 44 kb downstream LPLa 0.27 2.14E-10 4.09E-11 0.142 ± 0.02
rs1919484 8 19869676 45 kb downstream LPLa 0.27 4.12E-10 7.21E-11 -0.143 ± 
0.021
rs17259942 12 77072077 OSBPL8-ZDHHC17 0.12 8.61E-08 1.81E-08 0.168 ± 0.028
rs9989419 16 56985139 HERPUD1-CETPa HDL-C [4,7] 0.40 4.57E-13 5.96E-14 -0.147 ± 
0.019
rs1800775 16 56995236 0.5 kb upstream CETPa HDL-C [3,12] 0.45 1.54E-29 1.64E-30 0.242 ± 0.02
rs7240405 18 47159090 LIPGa-ACAA2b 0.16 8.01E-08 1.58E-08 -0.145 ± 
0.024
rs4939883 18 47167214 LIPGa-ACAA2b HDL-C [1,2] 0.17 1.07E-07 1.85E-08 0.142 ± 0.024
rs1943981 18 47169815 LIPGa-ACAA2b 0.17 1.49E-07 2.50E-08 0.142 ± 0.024
rs2156552 18 47181668 LIPGa-ACAA2b HDL-C [3,4] 0.16 5.87E-08 1.14E-08 -0.146 ± 
0.024
rs6507945 18 47243912 LIPGa-ACAA2b 0.43 4.34E-08 6.91E-09 0.113 ± 0.018
a This gene was reported in [1-4].
b This gene was reported in [3].Ma et al. BMC Medical Genetics 2010, 11:55
http://www.biomedcentral.com/1471-2350/11/55
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upstream RPL7P43. The other nineteen SNPs confirmed
previously reported gene regions, including twelve SNPs
8-45 kb downstream LPL, two SNPs 0.5-11 kb upstream
CETP, and five SNPs in the LIPG-ACAA2 region (39.812
kb downstream LIG and 65.963 kb upstream ACAA2) [1-
4,7,11,12].  LPL,  CETP  and  LIPG  w e r e  r e p o r t e d  t o  b e
associated with HDL-C in four recent GWAS reports [1-
4] while ACAA2 was reported in [3]. The SNP nearest to
CETP (rs1800775) was the most significant effect (p =
8.61 × 10-34) in this study.
QQ plot for single SNP tests on TC and HDL-C showed
that p-values of significant results all deviated from the
expected p-values under the null hypothesis (Figure 2).
Epistasis effects
Two epistasis effects on TC and thirteen epistasis effects
on HDL-C reached the significance of suggestive linkage
defined in [16] (Table 3). The two epistasis effects on TC
involved two different pairs of gene regions while the
thirteen epistasis effects on HDL-C involved five different
pairs of gene regions, so that the fifteen epistasis effects
identified seven pairs of gene regions. Eight SNPs in
introns 1, 5, 7, 9, and 14 of LMBRD1 (chr06) (Figure 1C)
interacted with a chr12 SNP about 53 kb from LRIG3
(q14.1, Figure 1D) and all these eight pairs had D × D
effects on HDL-C. One of the eight epistasis effects
involving intron 14 of LMBRD1 was the most significant
epistasis effect that was close to reaching "significant
Figure 1 Gene regions associated with total cholesterol (TC). A) A 1.23 Mb region containing RAB3GAP1-R3HDM1-LCT-MCM6 with multiple SNP 
effects on TC. B) One Mb region containing OSBPL8-ZDHHC17 associated with HDL-C. C) One Mb region containing LMBRD1 that had multiple SNPs 
interacting with an SNP near LRIG3 for TC. D) One Mb region containing LRIG3 which was near an SNP interacting with multiple SNPs in LMBRD1 for TC.











Ma et al. BMC Medical Genetics 2010, 11:55
http://www.biomedcentral.com/1471-2350/11/55
Page 5 of 11
linkage" defined in [16] or genome-wide significance with
5% Bonferroni corrected type-I error.
Among the seven different pairs of gene regions with
epistasis effects, four pairs had A × A effects, one pair had
A × D effect, and two pairs had D × D effects (Table 3).
For the A × A effect on TC involving chr04 and chr10, the
A-T gamete had the highest TC value while the A-G gam-
ete had the lowest TC value (Table 4). This showed that
the G and T alleles of rs705169 on chr10 had significantly
different effects when combined with the A allele of
rs4437278 on chr04, noting that rs705169 did not have
significant single-locus effect. The same phenomenon
was also observed for the other three A × A effects in
Table 4. For the A × D effect, the A-GG allele-genotype
combination had the highest TC value while the G-GG
allele-genotype combination had the lowest TC value.
The two D × D effects were on HDL-C. For the D × D
effect of rs4706271 × rs6581219 representing the eight
pairs of D × D effects involving the same gene regions,
GT-GG had the highest HDL-C value while GG-GG had
the lowest HDL-C value. For the remaining D × D effect
of rs12596869 × rs6506699 representing the two D × D
effects of the same gene regions, CC-AG had the highest
HDL-C value while CC-AA had the lowest HDL-C value
(Table 4).
Discussion
The single-locus results in this study had strong confir-
mations with existing studies. For TC, we confirmed
CELSR2 and ABCG5 reported in [1,8]. These confirmed
TC results should be considered as strong confirmation
because our study had no overlapping samples with stud-
i e s  o f  [ 1 , 8 ] .  W e  d e t e c t e d  s e v e n  e f f e c t s  o n  T C  i n  t h e
RAB3GAP1-R3HDM1-LCT-MCM6 region with the SNP
in  LCT  being the most significant. Six of these seven
effects had p-values for LDL-C in the range of 0.007-
0.056 from a meta-analysis ([2], Table 1). This could be an
indication about the significance on TC from a meta-
analysis because LDL-C is calculated from TC [17]. A
study in FINRISK cohorts with 14,140 individuals
reported that LCT was associated with both TC and LDL-
C with p-values in the range of 0.0005-0.005 [18]. In Silico
replication using 1231 Italian subjects from the InCHI-
ANTI cohort [19] generally lacked confirmation for the
TC results in Table 1. The first three markers had p-val-
ues in the range of 0.005-0.07 while the other effects had
p-values greater than 0.14 from the InCHIANTI cohort.
The biological function of LCT for digesting lactose could
be a reason for agreements and disagreements in replicat-
ing LCT effects on cholesterol. LCT affects lactose diges-
tion and long-term consumption of lactose in rats was
found to affect aortic cholesterol levels [20]. Therefore,
dietary lactose levels that have not been considered by
human GWAS could have affected the LCT results of dif-
ferent studies. MCM6  contains two of the regulatory
regions for LCT [21] so that the significant effects in or
near MCM6 (Table 1) could be due to MCM6's regulatory
role to LCT. HDL-C had twenty significant SNP effects,
but only one SNP identified a new gene region (OSBPL8-
ZDHHC17) while all the other SNPs confirmed previ-
ously reported gene regions, although only seven of the
twenty significant SNPs for HDL-C were reported previ-
Figure 2 QQ plots for single-SNP whole genome association tests of total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-
C). A) TC. B) HDL-C.
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Table 3: Epistasis effects for TC and HDL-C with the significance of suggestive linkage.
P value
SNP1 Chr1 Pos1 Gene1 MAF1 SNP2 Chr2 Pos2 Gene2 MAF2 Genotype Epistasis Effect
TC
rs4437278 4 12488199 U6a (174 kb) 0.15 rs705169 10 125285443 GRP26(140 kb) 0.49 4.49E-10 AA 5.93E-12 0.249 ± 0.036
rs4738150 8 72607907 U8a (120 kb) 0.40 rs16918936 9 33009027 APTX, LOC646808 0.04 4.68E-13 AD 1.29E-12 -1.348 ± 0.188
HDL-C
rs10476539 5 91991628 AC026781.5a (62 kb) 0.18 rs2392885 8 129003117 PVT1a 0.28 2.63E-10 AA 2.99E-12 -0.269 ± 0.037
rs4706271 6 70390132 LMBRD1(intron14) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 7.67E-11 DD 5.72E-13 -0.412 ± 0.056
rs7741758 6 70412380 LMBRD1(intron9) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 5.73E-10 DD 4.60E-12 -0.388 ± 0.054
rs9346333 6 70426479 LMBRD1(intron8) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 1.39E-10 DD 1.16E-12 -0.398 ± 0.054
rs9351772 6 70428200 LMBRD1(intron8) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 5.38E-10 DD 4.25E-12 -0.390 ± 0.055
rs7762400 6 70445634 LMBRD1(intron7) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 4.41E-10 DD 3.52E-12 -0.388 ± 0.054
rs9294851 6 70457629 LMBRD1(intron5) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 2.83E-10 DD 2.22E-12 -0.392 ± 0.054
rs9354890 6 70504296 LMBRD1(intron1) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 5.54E-10 DD 4.18E-12 -0.388 ± 0.054
rs9364063 6 70514750 LMBRD1(8 kb) 0.41 rs6581219 12 59213144 LRIG3(53 kb) 0.42 4.65E-10 DD 4.46E-12 -0.386 ± 0.054
rs2787520 6 106821428 ATG5(48 kb) 0.35 rs7236739 18 20800715 CABLES1(intron4) 0.31 2.98E-10 AA 2.48E-12 -0.211 ± 0.029
rs2842169 10 128330713 AL583860.7a (85 kb) 0.10 rs4756344 11 36765284 C11orf74(84 kb) 0.26 3.56E-10 AA 3.73E-12 0.348 ± 0.049
rs17623128 16 77630108 AC092724.2a (114 kb) 0.33 rs6506699 18 9775566 RAB31 0.49 4.65E-10 DD 2.78E-12 -0.449 ± 0.062
rs12596869 16 77630380 AC092724.2a (114 kb) 0.33 rs6506699 18 9775566 RAB31 0.49 3.81E-10 DD 2.30E-12 -0.451 ± 0.062
a This was an RNA gene.M
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Table 4: Frequency and effect of gamete, allele-genotype or genotype-genotype combination in each epistasis effect with statistical significance of suggestive 
linkage.
Trait SNP1 Chr1 SNP2 Chr2
Gamete A-T G-G G-T A-G
rs4437278 4 rs705169 10 Frequency 0.0785 0.413 0.434 0.0742
TC Effect 0.103 0.0195 -0.0186 -0.108
Allele-
genotype
A-GG G-GT A-TT G-TT A-GT G-GG
rs4738150 8 rs16918936 9 Frequency 0.0015 0.0284 0.557 0.374 0.0387 0.001
Effect 0.961 0.0917 0.00219 -0.00313 -0.0636 -1.42
Gamete A-C G-T G-C A-T
rs10476539 5 rs2392885 8 Frequency 0.0538 0.593 0.226 0.127
Effect 0.15 0.0137 -0.0359 -0.0635
Genotype
-genotype
GT-GG GG-AG GT-AA TT-AG TT-AA TT-GG GT-AG GG-AA GG-GG
rs4706271 6 rs6581219 12 Frequency 0.0817 0.0887 0.161 0.169 0.112 0.0619 0.24 0.055 0.0298
Effect 0.137 0.127 0.0694 0.066 -0.0495 -0.0908 -0.0932 -0.103 -0.189
Gamete G-G T-A G-A T-G
HDL-C rs2787520 6 rs7236739 18 Frequency 0.106 0.448 0.241 0.206
Effect 0.0946 0.0224 -0.0416 -0.0488
Gamete C-A T-G T-A C-G
rs2842169 10 rs4756344 11 Frequency 0.0751 0.237 0.661 0.0272
Effect 0.0801 0.0253 -0.00908 -0.221
Genotype CC-AG CT-AA CT-GG TT-AG TT-GG TT-AA CT-AG CC-GG CC-AA
rs12596869 16 rs6506699 18 Frequency 0.0501 0.103 0.115 0.208 0.131 0.115 0.215 0.0344 0.0279
Effect 0.223 0.109 0.0979 0.0535 -0.0433 -0.0494 -0.103 -0.167 -0.197Ma et al. BMC Medical Genetics 2010, 11:55
http://www.biomedcentral.com/1471-2350/11/55
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ously (Table 2). OSBPL8 encodes a group of intracellular
lipid receptors and suppresses ABCA1 [22], and ABCA1
was found to affect HDL-C level [23,24]. For HDL-C, the
InCHIANTI cohort did not confirm the effects in the
LIPG-ACAA region (p > 0.55) but confirmed the other
effects. In light of different samples and different meth-
ods of data analysis between our study and those in previ-
ous reports, the confirmations of gene results we
observed for TC and HDL-C should be considered strong
confirmations. This study used log-transformed TC and
HDL-C values while recent GWAS on TC [1] and HDL-C
[1-4] used the original observations of TC and HDL-C
that deviated from normal distribution. However, single-
locus effects from our study and previous studies [1-4]
had remarkable mutual confirmation, indicating that sin-
gle-locus analysis was somewhat robust to data distribu-
tion and possibly to methods of analysis.
Epistasis effects on TC and HDL-C were not reported
in other GWAS so that a comparison between our epista-
sis results and those from others was unavailable. We
detected eight SNP pairs indicating the interaction
between gene LMBRD1 and gene LRIG3 with the signifi-
cance of suggestive linkage. Both LMBRD1 and LRIG3
encode membrane proteins. LMBRD1 gene is involved in
the transportation and metabolism of vitamin B12 which
is important for metabolism of branched chain amino
acids and odd chain fatty acids [25]. Replication using the
InCHIANTI cohort did not confirm the epistasis results
(p > 0.15).
The statistical power of epistasis testing is less than that
for testing a single-locus effect, particularly for epistasis
effects involving dominance such as A × D and D × D
effects, with D × D effect being the most difficult to
detect. The reason for this difficulty was due to the fact
that higher-order effects explain less phenotypic variation
even if the effect sizes were the same as lower-order
effects [13]. The reduced power for epistasis testing could
have contributed to the fact that the epistasis effects we
detected only reached 'suggestive linkage' although the
sample size was over 6000. The data analysis of this study
showed that pairwise analysis was sensitive to outliers.
This was due to the fact that artificially significant epista-
sis effects could occur when rare combinations of loci had
extreme genotypic values by chance. This may happen
when outliers exist due to the large number of pairwise
effects arising from the large number of pairwise combi-
nations. For example, over 466 billion pairwise effects
(93,353,260,560 pairs × 5 effects per pair =
466,766,302,800 pairwise effects) were tested per trait in
t h i s  s t u d y .  A  s m a l l  f r a c t i o n  o f  r a n d o m  a s s o c i a t i o n
between rare frequencies and outliers in opposite direc-
tions among a large number of pairs could yield a long list
of artificially significant epistasis results. Therefore, deal-
ing with outliers such as removing outliers and using data
transformation is important in pairwise analysis. Pairwise
analysis is computationally intensive but timely analysis is
possible using parallel computing. Using 784 processor
cores on the SGI Altix XE 1300 Linux cluster system with
2.66 GHz Intel Clovertown processor at the Minnesota
Supercomputer Institute, the completion of pairwise
epistasis analysis required about 15 hours per trait.
Conclusions
Genome-wide association analysis of the FHS data
detected new single-locus and epistasis effects on TC and
HDL-C and confirmed some previously reported effects.
Additive effects were the primary single-locus effects of
TC and HDL-C while epistasis effects involved allele ×
allele, allele × genotype (or genotype × allele), and geno-
type × genotype interactions.
Methods
Phenotype and SNP data
The FHS GWAS data (version 2) had 6575 individuals
with SNP genotypes of the 500 k SNP panel from dbGAP.
Of the 6575 individuals, 6431 had observations on TC
and 6078 individuals had observations on HDL-C. A total
of 496,858 SNP markers had known chromosome loca-
tions and 432,096 of these SNP markers with minor allele
frequencies greater than or equal to 0.01 were analyzed.
Statistical Analysis
Original TC and HDL-C observations deviated from nor-
mality and had outliers (Figure 3A, D). The Box-Cox
transformation analysis [26] implemented by the R statis-
tical package [27] showed that the log-transformation
was approximately the best transformation to achieve
normality for those two traits (Figure 3B-C, E-F). One TC
outlier, the highest TC value, was removed from the data
analysis while no HDL-C outlier was removed. Log-trans-
formed TC values were adjusted for blood sugar, body
mass index, smoking status, and sex that had significant
effects on log(TC). Age, age-squared, cholesterol treat-
ment, and alcohol consumption were also tested for sig-
nificant effects on log(TC) but were not included in the
phenotypic model because they were insignificant.
Log(HDL-C) was adjusted for age, age-squared, choles-
terol treatment, blood sugar, body mass index, smoking
status, number of cigars smoked, alcohol consumption
and sex. Age was insignificant for HDL-C but was
included because age-squared was nearly significant (p <
0.0543). Single-locus and epistasis effects for both traits
were tested using the extended Kempthorne model that
allows Hardy-Weinberg disequilibrium and linkage dis-
equilibrium [13]. For each SNP, three effects were tested,
genotypic, additive (A) and dominance (D) effects. For
each SNP pair, five effects were tested, two-locus geno-
typic effect, A × A, A × D, D × A, and D × D epistasisMa et al. BMC Medical Genetics 2010, 11:55
http://www.biomedcentral.com/1471-2350/11/55
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effects. The EPISNPmpi parallel computing program [28]
with a modification to implement a generalized least
squares (GLS) analysis to account for sib correlations [29]
was used to implement the statistical tests of single-locus
and pairwise epistasis effects. For single-locus tests, p =
7.2 × 10-8 was used as the threshold p-value to declare
genome-wide significance [30]. To assess genome-wide
significance of pairwise epistasis results, we used 5%
type-I error with the Bonferroni correction as the
genome-wide significance. The 500 k SNP data was esti-
mated to have 276,666 independent SNPs [31]. Each pair-
wise test was considered to have four independent tests
although five effects were tested, because the two-locus
marker genotypic effect was confounded with one of the
four epistasis effects in reporting significant results.
Therefore, the genome-wide 5% type-I errors with the
Bonferroni correction was calculated as p = 0.05
[4(276,666)(276,665)/2]-1 = 3.266 × 10-13. This 5% signifi-
cance level is equivalent to "significant linkage" defined in
[16]. Since the Bonferroni correction is generally consid-
ered too severe, we also reported epistasis effects reach-
ing "suggestive linkage" with statistical evidence that
would be expected to occur one time at random in a
genome-wide analysis [16]. In addition to the GLS
method to account for sib correlation, the genomic con-
trol (GC) method [32] was used to account for potential
sub-population structures in the three generation cohort
of the FHS data set. For single-locus tests, all p-values
were used to estimate inflation parameters for TC and
HDL-C, yielding inflation parameter estimates of 1.14
and 1.11 respectively, and test statistics from the GLS
tests were then adjusted by the estimates of inflation
parameters and p-values were recalculated using the GC
adjusted test statistics, which resulted in fewer significant
effects. For the pairwise epistasis testing, we randomly
selected 50,000 p-values and test statistics from over 466
billion pairwise tests for computational efficiency. Then
we estimated the inflation parameters using two samples
of 50,000 data points each for TC and HDL-C, yielding
inflation parameter estimates of 1.01 and 1.05 respec-
Figure 3 Distributions of total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) in original scales and in log-transformed 
scales. A) Distribution of TC in original scale deviated from normality and had an outlier to the far right. B) The Box-Cox maximum likelihood analysis 
showed that log-transformation (λ ≈ 0) was the best transformation to achieve normality for TC. C) Log-transformed TC values achieved normality. 
One outlier to the far right was removed from the data analysis. D) Distribution of HDL-C in original scale deviated from normality and had some out-
liers to the right. E) The Box-Cox maximum likelihood analysis showed that log-transformation (λ ≈ 0) was the best transformation to achieve normality 
for HDL-C. F) Log-transformed HDL-C values achieved normality without serious outliers.
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tively. All p-values were then adjusted using the inflation
parameters and such adjustments also resulted in fewer
significant epistasis results. Frequency of each subclass in
an epistasis effect was calculated and each subclass was
required to have a minimal number of five observations.
After GC adjustment, QQ plots were made to show devi-
ations of the observed p-values from the expected p-val-
ues under the null hypothesis for significant test results
for single-locus tests only. QQ plot for epistasis effects
were not made because the number of p-values for
epistasis tests was too large. Gene locations of significant
SNPs were identified according to ENSEMBL [15] and
NCBI [14] based on Build 37.0 of the human genome.
List of abbreviations
GWAS:  genome-wide association study. SNP:  single
nucleotide polymorphism. TC: total cholesterol. HDL-C:
high-density lipoprotein cholesterol. LDL-C: low-density
lipoprotein cholesterol. LD:  linkage disequilibrium.
HWD: Hardy-Weinberg disequilibrium. A × A: additive
× additive epistasis effect. A × D: additive × dominance
epistasis effect. D × A: dominance × additive epistasis
effect. D × D: dominance × dominance epistasis effect.
GLS: generalized least squares.
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